Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:48:51.244Z.
Calculation as of: 2026-10-06T19:48:51.244Z.
Quote observation: 2026-10-06T19:42:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a0cb01cc31f7f7a1ab27ea5f4e27b2bab80fdffd2dde3b1d08905865647984d
PEG RATIO
N/A
Paranovus Entertainment Technology Ltd.
Market Cap
$3.27M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.27M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.26M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.20M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.12M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.35M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.11M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.54M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
